Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Tetra Bio-Pharma Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting June 02, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain May 11, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial May 06, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios May 05, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals May 04, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures COVID-19 Cannabis Intellectual Property Tickers TBPMF TSX:TBP Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada May 03, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority April 28, 2021 From Tetra Bio-Pharma Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial April 23, 2021 From Tetra Bio-Pharma Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis April 15, 2021 From Tetra Bio-Pharma Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers TBPMF TSX:TBP Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada April 14, 2021 From Tetra Bio-Pharma Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers TBPMF TSX:TBP Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.